オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/30 | 1,383 | 1,406 | 1,352 | 1,355 | -12 | -0.9% | 354,600 |
2020/04/28 | 1,317 | 1,378 | 1,314 | 1,367 | +42 | +3.2% | 230,100 |
2020/04/27 | 1,299 | 1,339 | 1,278 | 1,325 | +40 | +3.1% | 215,400 |
2020/04/24 | 1,330 | 1,330 | 1,279 | 1,285 | -29 | -2.2% | 248,400 |
2020/04/23 | 1,288 | 1,317 | 1,273 | 1,314 | +47 | +3.7% | 240,400 |
2020/04/22 | 1,340 | 1,340 | 1,264 | 1,267 | -81 | -6% | 355,200 |
2020/04/21 | 1,387 | 1,420 | 1,327 | 1,348 | -9 | -0.7% | 366,300 |
2020/04/20 | 1,332 | 1,376 | 1,332 | 1,357 | +12 | +0.9% | 156,900 |
2020/04/17 | 1,357 | 1,370 | 1,326 | 1,345 | -12 | -0.9% | 221,300 |
2020/04/16 | 1,361 | 1,369 | 1,327 | 1,357 | -13 | -0.9% | 157,100 |
2020/04/15 | 1,371 | 1,401 | 1,357 | 1,370 | -15 | -1.1% | 221,900 |
2020/04/14 | 1,344 | 1,415 | 1,336 | 1,385 | +65 | +4.9% | 426,600 |
2020/04/13 | 1,310 | 1,361 | 1,290 | 1,320 | -3 | -0.2% | 238,400 |
2020/04/10 | 1,350 | 1,374 | 1,295 | 1,323 | -34 | -2.5% | 248,900 |
2020/04/09 | 1,271 | 1,374 | 1,261 | 1,357 | +91 | +7.2% | 420,500 |
2020/04/08 | 1,256 | 1,278 | 1,219 | 1,266 | +9 | +0.7% | 205,500 |
2020/04/07 | 1,250 | 1,299 | 1,216 | 1,257 | +42 | +3.5% | 336,500 |
2020/04/06 | 1,168 | 1,237 | 1,160 | 1,215 | +38 | +3.2% | 341,800 |
2020/04/03 | 1,280 | 1,286 | 1,159 | 1,177 | -73 | -5.8% | 441,600 |
2020/04/02 | 1,231 | 1,285 | 1,224 | 1,250 | +8 | +0.6% | 270,900 |
2020/04/01 | 1,300 | 1,313 | 1,231 | 1,242 | -70 | -5.3% | 337,200 |
2020/03/31 | 1,370 | 1,386 | 1,307 | 1,312 | +17 | +1.3% | 376,900 |
2020/03/30 | 1,260 | 1,329 | 1,258 | 1,295 | -9 | -0.7% | 320,800 |
2020/03/27 | 1,375 | 1,394 | 1,286 | 1,304 | -56 | -4.1% | 599,100 |
2020/03/26 | 1,429 | 1,462 | 1,324 | 1,360 | -77 | -5.4% | 502,200 |
2020/03/25 | 1,448 | 1,505 | 1,409 | 1,437 | +19 | +1.3% | 702,900 |
2020/03/24 | 1,449 | 1,459 | 1,392 | 1,418 | +20 | +1.4% | 543,900 |
2020/03/23 | 1,371 | 1,430 | 1,341 | 1,398 | +1 | +0.1% | 388,300 |
2020/03/19 | 1,408 | 1,408 | 1,310 | 1,397 | +64 | +4.8% | 413,100 |
2020/03/18 | 1,417 | 1,482 | 1,313 | 1,333 | -54 | -3.9% | 650,400 |
2020/03/17 | 1,296 | 1,477 | 1,271 | 1,387 | +151 | +12.2% | 1,324,200 |
2020/03/16 | 1,322 | 1,360 | 1,227 | 1,236 | -42 | -3.3% | 662,800 |
2020/03/13 | 1,160 | 1,363 | 1,125 | 1,278 | -2 | -0.2% | 910,700 |
2020/03/12 | 1,259 | 1,377 | 1,247 | 1,280 | +22 | +1.7% | 969,400 |
2020/03/11 | 1,315 | 1,395 | 1,258 | 1,258 | -147 | -10.5% | 982,100 |
2020/03/10 | 1,108 | 1,431 | 1,051 | 1,405 | +274 | +24.2% | 1,711,500 |
2020/03/09 | 1,208 | 1,230 | 1,110 | 1,131 | -167 | -12.9% | 901,000 |
2020/03/06 | 1,418 | 1,506 | 1,276 | 1,298 | -168 | -11.5% | 1,053,000 |
2020/03/05 | 1,566 | 1,585 | 1,441 | 1,466 | -138 | -8.6% | 1,566,100 |
2020/03/04 | 1,320 | 1,604 | 1,320 | 1,604 | +300 | +23% | 2,223,700 |
2020/03/03 | 1,411 | 1,447 | 1,283 | 1,304 | -47 | -3.5% | 650,700 |
2020/03/02 | 1,218 | 1,458 | 1,195 | 1,351 | +193 | +16.7% | 1,371,500 |
2020/02/28 | 1,235 | 1,302 | 1,145 | 1,158 | -191 | -14.2% | 1,399,200 |
2020/02/27 | 1,482 | 1,512 | 1,325 | 1,349 | -160 | -10.6% | 878,600 |
2020/02/26 | 1,613 | 1,625 | 1,454 | 1,509 | -120 | -7.4% | 813,400 |
2020/02/25 | 1,620 | 1,690 | 1,620 | 1,629 | -97 | -5.6% | 264,500 |
2020/02/21 | 1,718 | 1,743 | 1,718 | 1,726 | -7 | -0.4% | 98,300 |
2020/02/20 | 1,750 | 1,762 | 1,722 | 1,733 | -18 | -1% | 144,400 |
2020/02/19 | 1,714 | 1,761 | 1,711 | 1,751 | +31 | +1.8% | 178,300 |
2020/02/18 | 1,760 | 1,782 | 1,716 | 1,720 | -60 | -3.4% | 248,600 |
1301~
1350
件表示中 / 2861件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
扶桑薬 | 220,300円 | +1.6% | -12.7% | 4.09% | 8.18倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム